A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis. [electronic resource]
Producer: 20020103Description: 1051-64 p. digitalISSN:- 1170-7690
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- drug therapy
- Costs and Cost Analysis
- Etanercept
- Female
- Humans
- Immunoglobulin G -- administration & dosage
- Infliximab
- Male
- Netherlands -- epidemiology
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Reproducibility of Results
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.